N
Nextgenbio
The startup develops a therapeutic drug platform targeting fibrosis through clinical trials, focusing on conditions such as wet macular degeneration, non-alcoholic steatohepatitis, and pulmonary fibrosis. This platform addresses the unmet medical need for effective treatments in patients suffering from refractory fibrosis diseases.
Traction –/10
성남시, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a therapeutic drug platform targeting fibrosis through clinical trials, focusing on conditions such as wet macular degeneration, non-alcoholic steatohepatitis, and pulmonary fibrosis. This platform addresses the unmet medical need for effective treatments in patients suffering from refractory fibrosis diseases.